CS Paper Radar

An Explainable Machine Learning Framework for Predicting Blood-Brain Barrier Permeability Using Molecular Descriptors

Fatemeh Mahmoudi

cs.LG cond-mat.mtrl-sci ·submitted 2026-09-09 10:42 UTC · v1
code/data

Abstract

Blood-brain barrier (BBB) permeability is a critical determinant in the development of central nervous system therapeutics because it directly influences the ability of drug candidates to reach their target sites within the brain. In this study, an explainable machine learning framework was developed to predict BBB permeability using molecular descriptors generated from the MoleculeNet BBBP dataset with the RDKit cheminformatics toolkit. Fifteen physicochemical descriptors extracted from 2,039 compounds were used to train four supervised machine learning algorithms, including Logistic Regression, Support Vector Machine (SVM), Random Forest, and Extreme Gradient Boosting (XGBoost). Hyperparameter optimization was performed using GridSearchCV, while model interpretability was investigated using SHapley Additive exPlanations (SHAP). Among the evaluated models, the optimized XGBoost classifier achieved the best predictive performance, with an accuracy of 88.97%, a precision of 88.92%, a recall of 97.76%, an F1-score of 93.13%, and a ROC-AUC of 0.9282. Stratified five-fold cross-validation further demonstrated the robustness of the proposed model, yielding a mean ROC-AUC of 0.8982 +/- 0.0130. Feature importance and SHAP analyses consistently identified TPSA, HBD, and LogP as the most influential molecular descriptors governing BBB permeability prediction. Overall, the proposed framework provides an accurate, interpretable, and computationally efficient approach for BBB permeability prediction and may serve as a valuable tool for the early-stage screening of CNS drug candidates.

Comment
19 pages, 6 figures, 4 tables. Source code and processed data are publicly available on GitHub

Closest papers

Nearest neighbours by meaning across the whole index.

Feature Space Selection and Heterogeneous Effect Estimation for Blood-Brain Barrier Permeability: A Random Forest to the Generalized Random Forest Pipeline

cs.LG stat.ML ·2026-09-24 ·Tshemollo Rapolai, Seite Makgai, Mohammad Arashi
similarity 0.76
Abstract

Predicting blood-brain barrier (BBB) permeability is critical for central nervous system drug discovery. Using the MoleculeNet BBBP dataset (n = 2039), this study systematically ablates molecular feature spaces to isolate featurisation from model architecture. We evaluate three feature families (Morgan fingerprints, RDKit physicochemical descriptors, SMILES bigrams) across four learning algorithms. Results demonstrate that predictive performance depends jointly on feature representation and algorithm. Dynamic Random Forest using combined features achieved the highest mean AUC (0.970, 95% CI: 0.963-0.977). Second, this optimal representation enables exploratory estimation of heterogeneous associations between molecular structure and BBB permeability using Generalized Random Forests. Constructing a pseudo-treatment from a LogP median split, we applied double/debiased machine learning to account for confounding. Orthogonalization substantially attenuates the heterogeneity detected by naive causal forests; no conditional effects remained significant after false discovery rate correction (smallest adjusted p = 0.082). Furthermore, orthogonalized feature importance shifted toward residual structural information in SMILES bigrams. Ultimately, once observed confounding is properly accounted for, evidence that LogP-BBB associations vary systematically across chemical space is insufficient. This underscores that feature representation and model architecture are coupled design choices, and that unorthogonalized causal forests risk overstating genuine treatment effect heterogeneity.

0.09

Hybrid Machine Learning-Assisted Raman Spectroscopy with Generative Feature Augmentation for Pharmaceutical Identification

cs.LG cond-mat.mtrl-sci ·2026-09-18 ·Quach Thi Thai Binh, Ton Nu Quynh Trang, Thang B. Phan, Vu Thi Hanh Thu, Nguyen Tuan Hung
similarity 0.61
Abstract · 12 pages, 7 figures, 2 tables

Rapid and reliable identification of pharmaceutical residues is important for safeguarding public health, ensuring food safety, and enabling practical Raman-based screening. In this study, we propose HyMLRaman, a hybrid Raman spectroscopy framework that combines deep spectral feature extraction, generative models, and classical machine-learning classifiers to identify six pharmaceutical compounds, including amoxicillin, chloramphenicol, ciprofloxacin, tetracycline, ibuprofen, and paracetamol. Raman spectra are converted into spectral images and encoded with several deep neural-network backbones, among which EfficientNet-B3 yields the most effective representation. The resulting 1536-dimensional embeddings are then used to train downstream classifiers, including SVM, KNN, logistic regression, random forest, XGBoost, and ANN, using stratified 10-fold cross-validation. The hybrid EfficientNet-B3--SVM configuration achieves the strongest baseline performance, reaching 96.31% accuracy and a macro-F1 score of 96.36%, outperforming the standalone CNN baseline. To address limited-data conditions, a generative model, a DDPM-based feature augmentation, is introduced in a PCA-reduced EfficientNet-B3 latent space. The low-data ablation results show that DDPM augmentation provides selective benefits, particularly for KNN with reduced training fractions, and that its effect remains classifier-dependent. Finally, an application-level Raman Pharmaceutical Analyzer demonstrates the feasibility of embedding the trained model into an interactive Raman analysis workflow. These results suggest that HyMLRaman provides a practical and interpretable route for rapid Raman-based pharmaceutical screening.

0.19

EMFE: A lightweight, explainable machine learning framework for malaria cell classification

cs.CV ·2026-08-25 ·Md Abdullah Al Kafi, Walayat Hussain, Mousumi Karmakar, Sumit Kumar Banshal, Ahmed Al Marouf
similarity 0.57
Abstract

Automated malaria diagnosis from stained blood-smear microscopy is dominated by deep convolutional neural networks that are accurate but computationally expensive, poorly interpretable, and rarely validated with patient-level rigor. We present EMFE (Efficient Mathematical Feature Extraction), a five-feature framework for classifying single red-blood-cell images as parasitized or uninfected using Gray World color normalization, adaptive green-channel thresholding, morphological spot detection, and classical machine learning. Using the NIH LHNCBC malaria dataset (27,558 images from 200 patients), we evaluate Random Forest, Histogram Gradient Boosting, and Support Vector Machine classifiers under patient-grouped nested cross-validation (K_outer=20, K_inner=3), ensuring that cells from each patient remain within a single fold. The optimized Random Forest achieves 94.6% pooled out-of-fold accuracy (95% CI [93.6, 95.7]), corroborated by an untouched 40-patient holdout test (94.3%) and a patient-level permutation test (p<0.001, 1,000 permutations). Ablation experiments quantify the contribution of individual features and pipeline stages. Hardware-matched comparisons with retrained DenseNet121, ResNet50, and MobileNetV2 models assess the accuracy-efficiency trade-off. Synthetic perturbations characterize three failure modes, while explainability analysis identifies spot saturation as the dominant discriminative feature. Patient-level aggregation further quantifies sensitivity-specificity trade-offs and false-positive accumulation. These results demonstrate a statistically rigorous, interpretable, and computationally lightweight alternative to deep learning, while explicitly quantifying its limitations.

0.24

Benchmarking Machine-Learning Classifiers for Neoantigen Immunogenicity Prediction and the Limits of SHAP Interpretability

cs.AI cs.LG ·2026-10-31 ·Ramon Gonzalez
benchmark similarity 0.57
Abstract · 23 pages, 8 figures, 7 tables

Personalized cancer vaccines require prioritizing, among hundreds of candidate mutant peptides, the few that will induce a T-cell response. This study asks what general-purpose machine learning achieves on that task, and whether the features such models identify as important can be trusted. We make three contributions. The first is a benchmark of sixty models: twelve supervised classifier families, each in five configurations, evaluated on the Immunogenic Tumor Specific Neoantigen database (ITSNdb; 199 experimentally validated neoantigens, 129 immunogenic and 70 non-immunogenic). All sixty are compared under one stratified k-fold cross-validation protocol, in which the data used to choose a configuration are never the data used to score it. The second is an interpretability study that combines SHAP with feature ablation. The third is a shuffled-label control that tests whether a SHAP value has been earned. Two results follow, and both run against current practice. First, the classical linear models lead the ranking. The gradient-boosted ensembles and neural networks that dominate recent work bring no advantage. Second, SHAP can fail on high-cardinality categorical features. Ablation establishes the presenting HLA allele as the dominant input and the source gene as dispensable. SHAP reports the opposite, assigning 68.7% to 81.7% of its total value to the source gene in every model that gives each gene its own weight. Shuffling the gene labels at random among the peptides resolves the contradiction: the meaningless column earns the same SHAP value as the real one. That value measures only that ITSNdb contains 173 genes for 199 peptides. We therefore recommend that SHAP values for high-cardinality categorical annotations in cohorts of this size always be reported against such a shuffled-label control, and we describe one in full.

0.35

MolExplain: An Interactive Tool for Explainable Molecular Property Prediction

cs.HC physics.chem-ph ·2026-09-21 ·Pirm Dhararag, Dylan Cashman
similarity 0.57
Abstract

The application of machine learning to molecular property prediction has become increasingly prevalent in drug discovery, yet most models operate as black boxes, returning a prediction without revealing which structural features drive it. MolExplain addresses this gap by combining property prediction with sub-structure level visual explainability in an interactive web interface. The system featurizes molecules as Morgan fingerprints, classifies them using a trained XGBoost model, and applies SHAP attribution to produce a smooth heatmap overlay indicating which regions of the molecule contribute for or against the predicted property. Applied to cyclic peptide membrane permeability, the tool's attribution independently recovers the known role of backbone N-methylation in improving passive membrane diffusion, consistent with established chemistry. While demonstrated on cyclic peptides, the framework is designed to generalize to other molecular properties, positioning MolExplain as a platform for interactive, explainability-driven molecular design.

0.11

Impact of canny edge detection preprocessing on performance of machine learning models for Parkinson's disease classification

cs.LG cs.CV ·2026-09-07 ·Sameer Bhat, Piotr Szczuko
publishedhighly cited similarity 0.57
Abstract

This study investigates the classification of individuals as healthy or at risk of Parkinson's disease using machine learning (ML) models, focusing on the impact of dataset size and preprocessing techniques on model performance. Four datasets are created from an original dataset: DS_0, (normal dataset), DS_1 (DS_O subjected to Canny edge detection and Hessian filtering), DS_2 (augmented DS_0), and DS_3 (augmented DS_1). We evaluate a range of ML models-Logistic Regression (LR), Decision Tree (DT), Random Forest (RF), Gradient Boosting (GB), XGBoost (XBG), Naive Bayes (NB), Support Vector Machine (SVM), and AdaBoost (AdB)-on these datasets, analyzing prediction accuracy, model size, and prediction latency. The results show that while larger datasets lead to increased model memory footprints and prediction latencies, the Canny edge detection preprocessing supplemented by Hessian filtering (used in DS_1 and DS_3) degrades the performance of most models. In our experiment, we observe that Random Forest (RF) maintains a stable memory footprint of 61 KB across all datasets, while models like KNN and SVM show significant increases in memory usage, from 5.7-7 KB on DS_0 to 102-220 KB on DS_2, and similar increases in prediction time. Logistic Regression, Decision Tree, and Naive Bayes show stable memory footprints and fast prediction times across all datasets. XGBoost's prediction time increases from 180-200 ms on DS_0 to 700-3000 ms on DS_2 (truncated)

0.77

A Trustworthy Clinical Decision Support Framework for Brain Tumor MRI Classification: Integrating Attention-Guided Learning, Explainable AI, and Out-of-Distribution Validation

cs.CV cs.AIcs.LG ·2026-10-06 ·Arjun Kumar Gupta, Harminder Pal Monga
publishedbenchmark similarity 0.56
Abstract · Accepted for presentation at the IC3AI-2026 IEEE conference in Dec 2026. It has been accepted/selected but is not yet published. 6 pages, 4 …

Deep learning models for brain tumor diagnosis need to do more than achieve high classification accuracy. For practical use, they should also provide understandable predictions, recognize unsuitable inputs, and work within a usable clinical system. This paper presents a framework for classifying brain MRI into four categories: glioma, meningioma, pituitary tumor, and no tumor. The model uses InceptionResNetV2 with a Convolutional Block Attention Module (CBAM), while Grad-CAM provides visual explanations of its predictions. A two-stage out-of-distribution (OOD) mechanism screens unsuitable inputs using an initial grayscale check followed by Mahalanobis distance, softmax confidence, and predictive entropy. These components are brought together in NeuroScan AI, a real-time web application. Evaluated on a Mendeley brain tumor MRI dataset of 12,064 images, the framework achieved 98.70% validation accuracy, 96.73% test accuracy, and a macro-average AUC of 0.9965. The OOD pipeline achieved 99% detection accuracy on a preliminary 100-image benchmark. Grad-CAM visualizations showed qualitative correspondence with clinically established tumor locations across all four classes. Overall, the work brings classification, explainability, input validation, and deployment into one framework, while recognizing that broader clinical and OOD validation is still required.

0.25

Potential of Artificial Intelligence Algorithms for Identification of Relevant Diagnostic and Prognostic Biomarkers of Early-Stage Liver Cancer

cs.AI ·2026-09-14 ·Ali Bou Nassif, Darko Castven, Manar Abu Talib, Jibran Sualeh Muhammad, Ahmed Ammar Kubba +2 more
hot direction similarity 0.56
Abstract · 25 pages, 11 figures, 4 tables, under review

This study explores the use of deep learning and explainable artificial intelligence to diagnose hepatocellular carcinoma (HCC) and define effective biomarkers across five different stages of disease development using a transcriptomic biomarker HCC dataset constructed via semi-supervised learning from three source datasets. Several deep learning experiments were conducted with different feature extraction techniques and gene sets to identify the most effective features for training high-accuracy models with minimal loss. The best-performing model, using 15 selected genes with the SelectKBest algorithm, achieved 90.74% accuracy, while the model with the lowest recorded loss of 0.3187 was obtained using 20 selected genes. To address the issue of class imbalance in the dataset, a weighted training approach was conducted, and for model transparency and interpretability a SHAP-based XAI analysis provided insights into the model's decision-making, consistently finding DNAJB14 as the most influential gene. Functional validation in this study has provided compelling evidence that DNAJB14 plays an important role in the adverse properties of HCC and that its inhibition effectively reverses tumour cell migration, invasion, colony and sphere formation. The main limitation of this study is the dataset's class imbalance, and while weighted training helped mitigate this, further research and additional data are needed to guarantee model generalizability. Future studies should also explore the influence of genetic variations, environmental factors, and clinical differences on model performance across diverse populations.

0.34